A Proteomics Signature of NASH - Non-Invasive Assessment of Nonalcoholic Fatty Liver Disease
Offered By: Labroots via YouTube
Course Description
Overview
Explore the latest advancements in proteomics for diagnosing and monitoring nonalcoholic steatohepatitis (NASH) in this comprehensive webinar presented by Dr. Arun Sanyal. Delve into the global prevalence of nonalcoholic fatty liver disease (NAFLD) and the urgent need for non-invasive diagnostic tools. Learn about the development and validation of proteomics-based models for assessing key liver biopsy components and at-risk NASH. Discover how these innovative "liquid biopsy" techniques could revolutionize NAFLD assessment, potentially replacing invasive liver biopsies. Gain insights into ongoing clinical trials, disease progression, and effective strategies for managing NASH. Engage with cutting-edge research on serum protein profiling and its implications for diagnosis, prognosis, and monitoring of NAFLD and NASH.
Syllabus
Introduction
Liver Journey
Effective Strategies
Collaborative Project
Data Summary
Disease Progression
Pivence Trial
Flint Study
Clinical Trials
Summary
Live QA
Taught by
Labroots
Related Courses
Advances in Lung Cancer Treatment and Diagnosis from Stanford Health CareStanford University via YouTube Ultrasensitive and Ultraselective Liquid Biopsy: Nanophotonics-Driven Digital Resolution Biomolecule Sensing - Spring 2023
Stanford University via YouTube ctDNA for Minimal Disease Research by Hybridization Capture in Resected Cancer Samples
Integrated DNA Technologies (IDT) via YouTube Liquid Biopsy in Head and Neck Cancer: From Diagnosis to Survivorship
Stanford Otolaryngology — Head & Neck Surgery via YouTube EIC Accelerator Challenge: Novel Biomarker-Based Assays for Personalized Cancer Treatment
EU Innovation Council and SMEs Executive Agency via YouTube